4 ms·
It's interesting how small some of those grants and funding pools are compared to what you see in startup land. Maybe this is just the economics of viral resea
by 8f2ab37a-ed6c 5y ago
It's interesting how small some of those grants and funding pools are compared to what you see in startup land.
Maybe this is just the economics of viral research, but you'd think that with plenty of people out there willing to pay to cure themselves of HSV, or prevent it, there would be more financial support.
Yet, the people working on the problem have as much funding as the YC Standard Deal announced this month. I wonder why.
- e4e78a06 5y agoVaccines and cures deliver one time revenue, whereas treatments deliver perpetually recurring revenue. It's a well known market failure in healthcare.
- TaylorAlexander 5y agoI feel the same way. So much money gets thrown around to solve relatively trivial problems, but I suppose it is like a casino where you hope to win. Whereas no one funding this research expects a financial return. But you’d think that for example you could consider the tax payers as a body which would generally appreciate a cure to HSV. We could imagine the government funding such things. We just dropped an F-35 in the ocean in the South China Sea. I wonder how much research you could fund for the price of one of those.
- xeromal 5y agoYeah, after seeing game studios being bought for 64B dollars, how many HSVs could that cure?